Filing Flows

Filing Flows › Relay Therapeutics (RLAY) › Who owns the stock

Who owns Relay Therapeutics (RLAY) stock

249 funds reported Relay Therapeutics (RLAY) shares in their latest 13F filings, worth $4.6B in all. The largest holder is SB Investment Advisers (uk) ($522M). Last quarter 150 funds added to their stakes and 88 cut them.

Largest holders of RLAY (13F)Largest holders of RLAY (13F)SB Investment Advisers (uk)$522MFMR LLC$376MCasdin Capital, LLC$300MBlackRock$286MPerceptive Advisors LLC$264MCommodore Capital LP$225MState Street$189MVanguard Capital Management LLC$168MPrice T Rowe Associates$144MNextech Invest$127M

Largest holders (13F)

FundSharesValueChangeQuarter
SB Investment Advisers (uk)27,904,963$522Munchanged2026-06-30
FMR LLC20,110,113$376Mincrease2026-06-30
Casdin Capital, LLC16,035,240$300Mincrease2026-06-30
BlackRock15,288,202$286Mincrease2026-06-30
Perceptive Advisors LLC14,106,187$264Mincrease2026-06-30
Commodore Capital LP12,000,000$225Mdecrease2026-06-30
State Street10,125,381$189Mincrease2026-06-30
Vanguard Capital Management LLC8,964,423$168Mincrease2026-06-30
Price T Rowe Associates7,708,507$144Mincrease2026-06-30
Nextech Invest6,776,506$127Mincrease2026-06-30
Bellevue Group AG6,185,970$116Mdecrease2026-06-30
Geode Capital Management, LLC4,726,576$88.4Mincrease2026-06-30
Vanguard Group9,691,445$82.0Mincrease2025-12-31
TCG Crossover Management, LLC4,273,356$80.0Munchanged2026-06-30
Morgan Stanley3,851,071$72.1Mincrease2026-06-30

Relay Therapeutics' latest quarter

Relay Therapeutics, Q2 2026: revenue $350K (-48% year over year), net loss $83.7M, operating cash flow −$54.1M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most RLAY stock?

By the latest 13F filings: SB Investment Advisers (uk) ($522M); FMR LLC ($376M); Casdin Capital, LLC ($300M); BlackRock ($286M); Perceptive Advisors LLC ($264M).

What is the short interest in RLAY?

44,026,826 shares were sold short at the 2026-10-15 settlement, -5.82% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.